This is a genome-wide association study (GWAS) of global brain tissue volumes in human infants. The published study for this project includes 561 infants, and 239 parents gave consent for data sharing through dbGaP. An intronic single-nucleotide polymorphism (SNP) in IGFBP7 (rs114518130; <a href="https://www.ncbi.nlm.nih.gov/gene/?term=IGFBP7">GeneID: 3490</a>) met genome-wide significance for gray matter volume (P=4.15x10-10). An intronic SNP in WWOX (rs10514437; <a href="https://www.ncbi.nlm.nih.gov/gene/?term=WWOX">GeneID: 51741</a>) neared genome-wide significance for white matter volume (P=1.56x10-8). Additional loci with small P-values include psychiatric GWAS associations and transcription factors expressed in the developing brain. Genetic risk scores for schizophrenia and ASD, and the number of genes affected by rare copy number variants (CNV burden) did not predict global brain tissue volumes. Integrating these results with large-scale GWAS in adolescents [Philadelphia Neurodevelopmental Cohort (PNC)] and adults [Enhancing Neuro Imaging Genetics through Meta-Analysis version 2 (ENIGMA2)] suggested minimal overlap between common variants impacting brain volumes at different ages.

Genome-wide Identification of Variants Affecting Early Human Brain Development

Placental genomic risk scores and early neurodevelopmental outcomes

Genome-wide association analysis identifies common variants influencing infant brain volumes

Environmental and Genetic Contributors to Salivary Testosterone Levels in Infants

Genome-Wide Association Analysis of Neonatal White Matter Microstructure.